Statement of Changes in Beneficial Ownership (4)
July 02 2019 - 5:37PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Rittenmeyer Ronald A
|
2. Issuer Name
and
Ticker or Trading Symbol
TENET HEALTHCARE CORP
[
THC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Chairman and CEO
|
(Last)
(First)
(Middle)
1445 ROSS AVENUE, SUITE 1400
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/28/2019
|
(Street)
DALLAS, TX 75202
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
(1)
|
6/28/2019
|
|
M
|
|
62908
|
A
|
(2)
|
240080
|
D
|
|
Common Stock
|
6/28/2019
|
|
F
|
|
24755
(3)
|
D
|
$20.66
|
215325
|
D
|
|
Common Stock
|
|
|
|
|
|
|
|
15000
|
I
|
By spouse
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
2019 February Restricted Stock Units
|
(1)
|
6/28/2019
|
|
M
|
|
|
62908
|
(1)
|
(1)
|
Common Stock
(4)
|
62908
|
$0.00
|
503264
|
D
|
|
Explanation of Responses:
|
(1)
|
As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The first vesting date occurred on June 28, 2019 (the business day prior to June 30, 2019, which fell on a weekend), resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 503,264 restricted stock units are shown in Table II.
|
(2)
|
Restricted stock units convert into common stock on a one-for-one basis.
|
(3)
|
Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
|
(4)
|
Restricted stock units are settled in shares of the Company's common stock upon vesting.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Rittenmeyer Ronald A
1445 ROSS AVENUE, SUITE 1400
DALLAS, TX 75202
|
X
|
|
Executive Chairman and CEO
|
|
Signatures
|
Anthony L. Shoemaker, as Attorney-in-Fact for Ronald A. Rittenmeyer
|
|
7/2/2019
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Apr 2023 to Apr 2024